Human trials of Neuralink's brain chip to begin in UK
What's the story
Elon Musk's Neuralink is gearing up to conduct a clinical study in UK. The research will explore how its advanced brain chips can help patients with severe paralysis, control digital and physical tools using their thoughts. The firm has partnered with University College London Hospitals Trust and Newcastle Hospitals for this groundbreaking study.
Criteria
Who can apply for the trial?
Neuralink has announced that patients suffering from paralysis due to spinal cord injury or a nervous system disease called Amyotrophic Lateral Sclerosis (ALS), are eligible to take part in the study. To recall, Neuralink started human trials on its brain implant in 2024 after addressing the safety concerns flagged by the US Food and Drug Administration (FDA).
Finance
Neuralink has raised $1.3B in funding
Neuralink has revealed that five patients suffering from severe paralysis are already using its device to control digital and physical tools with their thoughts. The company, which was founded in 2016, has raised about $1.3 billion from investors and is valued at around $9 billion. It raised $650 million in its latest funding round last month.